Literature DB >> 19481407

National trends in lower extremity bypass surgery, endovascular interventions, and major amputations.

Philip P Goodney1, Adam W Beck, Jan Nagle, H Gilbert Welch, Robert M Zwolak.   

Abstract

INTRODUCTION: Advances in endovascular interventions have expanded the options available for the invasive treatment of lower extremity peripheral arterial disease (PAD). Whether endovascular interventions substitute for conventional bypass surgery or are simply additive has not been investigated, and their effect on amputation rates is unknown.
METHODS: We sought to analyze trends in lower extremity endovascular interventions (angioplasty and atherectomy), lower extremity bypass surgery, and major amputation (above and below-knee) in Medicare beneficiaries between 1996 and 2006. We used 100% samples of Medicare Part B claims to calculate annual procedure rates of lower extremity bypass surgery, endovascular interventions (angioplasty and atherectomy), and major amputation between 1996 and 2006. Using physician specialty identifiers, we also examined trends in the specialty performing the primary procedure.
RESULTS: Between 1996 and 2006, the rate of major lower extremity amputation declined significantly (263 to 188 per 100,000; risk ratio [RR] 0.71, 95% confidence interval [CI] 0.6-0.8). Endovascular interventions increased more than threefold (from 138 to 455 per 100,000; RR = 3.30; 95% CI: 2.9-3.7) while bypass surgery decreased by 42% (219 to 126 per 100,000; RR = 0.58; 95% CI: 0.5-0.7). The increase in endovascular interventions consisted both of a growth in peripheral angioplasty (from 135 to 337 procedures per 100,000; RR = 2.49; 95% CI: 2.2-2.8) and the advent of percutaneous atherectomy (from 3 to 118 per 100,000; RR = 43.12; 95% CI: 34.8-52.0). While radiologists performed the majority of endovascular interventions in 1996, more than 80% were performed by cardiologists and vascular surgeons by 2006. Overall, the total number of all lower extremity vascular procedures almost doubled over the decade (from 357 to 581 per 100,000; RR = 1.63; 95% CI: 1.5-1.8).
CONCLUSION: Endovascular interventions are now performed much more commonly than bypass surgery in the treatment of lower extremity PAD. These changes far exceed simple substitution, as more than three additional endovascular interventions were performed for every one procedure declined in lower extremity bypass surgery. During this same time period, major lower extremity amputation rates have fallen by more than 25%. However, further study is needed before any causal link can be established between lower extremity vascular procedures and improved rates of limb salvage in patients with PAD.

Entities:  

Mesh:

Year:  2009        PMID: 19481407     DOI: 10.1016/j.jvs.2009.01.035

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  123 in total

1.  Variation in the use of lower extremity vascular procedures for critical limb ischemia.

Authors:  Philip P Goodney; Lori L Travis; Brahmajee K Nallamothu; Kerianne Holman; Bjoern Suckow; Peter K Henke; F Lee Lucas; David C Goodman; John D Birkmeyer; Elliott S Fisher
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-12-06

2.  An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II): The TASC Steering Comittee(.).

Authors:  Michael R Jaff; Christopher J White; William R Hiatt; Gerry R Fowkes; John Dormandy; Mahmood Razavi; Jim Reekers; Lars Norgren
Journal:  Ann Vasc Dis       Date:  2015-10-23

3.  Domains that Determine Quality of Life in Vascular Amputees.

Authors:  Bjoern D Suckow; Philip P Goodney; Brian W Nolan; Ravi K Veeraswamy; Patricia Gallagher; Jack L Cronenwett; Larry W Kraiss
Journal:  Ann Vasc Surg       Date:  2015-02-26       Impact factor: 1.466

4.  Bleeding Complications in Lower-Extremity Peripheral Vascular Interventions: Insights From the NCDR PVI Registry.

Authors:  Bhaskar Bhardwaj; John A Spertus; Kevin F Kennedy; W Schuyler Jones; David Safley; Thomas T Tsai; Herbert D Aronow; Amit N Vora; Yashashwi Pokharel; Arun Kumar; Robert R Attaran; Dmitriy N Feldman; Ehrin Armstrong; Anand Prasad; Bruce Gray; Adam C Salisbury
Journal:  JACC Cardiovasc Interv       Date:  2019-06-24       Impact factor: 11.195

5.  Decrease in major amputations in Germany.

Authors:  Frans Santosa; Theodoros Moysidis; Susanne Kanya; Zeynep Babadagi-Hardt; Bernd Luther; Knut Kröger
Journal:  Int Wound J       Date:  2013-06-06       Impact factor: 3.315

6.  Monitoring the practice of vascular surgery: findings from a national registry (1996-2011).

Authors:  Francisco S Lozano; Josep Marinello; Rosa M Moreno; Maria D Aguilar; Alfonso López-Quintana; Jose R Gonzalez-Porras; Javier Alvarez; Antonio Giménez-Gaibar; Rafael Alguacil; Marc A Cairols; Miguel A Marco-Luque; Fernando Vaquero; José M Callejas
Journal:  World J Surg       Date:  2014-01       Impact factor: 3.352

7.  Outcomes of endovascular lower extremity interventions depend more on indication than physician specialty.

Authors:  Justin R Wallace; Theodore Yuo; Luke Marone; Rabih A Chaer; Michel S Makaroun
Journal:  J Vasc Surg       Date:  2013-10-03       Impact factor: 4.268

Review 8.  [Percutaneous mechanical atherectomy for treatment of peripheral arterial occlusive disease].

Authors:  A Buecker; P Minko; A Massmann; M Katoh
Journal:  Radiologe       Date:  2010-01       Impact factor: 0.635

9.  Trends and determinants of costs associated with the inpatient care of diabetic foot ulcers.

Authors:  Caitlin W Hicks; Shalini Selvarajah; Nestoras Mathioudakis; Bruce A Perler; Julie A Freischlag; James H Black; Christopher J Abularrage
Journal:  J Vasc Surg       Date:  2014-06-14       Impact factor: 4.268

10.  Unplanned early hospital readmissions in a vascular surgery population

Authors:  Alexandra Papadopoulos; Sue Devries; Janice Montbriand; Naomi Eisenberg; Charles de Mestral; Graham Roche-Nagle
Journal:  Can J Surg       Date:  2019-12-01       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.